Albert Bourla Dvm
Group President of Pfizer Innovative Health
Business
Pfizer Inc
United States of America
Biography
Mr. Albert Bourla, DVM, Ph.D., has been Group President of Pfizer Innovative Health at Pfizer Inc. since June 2016. Mr. Bourla served as Group President of Global Innovative Pharma & Global Vaccines, Oncology & Consumer Healthcare Businesses at Pfizer Inc. since February 12, 2016 until July 1, 2016. Mr. Bourla served as Group President of the Vaccines, Oncology and Consumer Healthcare Business at Pfizer Inc. since January 1, 2014. Mr. Bourla served as President and General Manager of Established Products Business Unit at Pfizer Inc., from December 2010 to December 2013 and served as its Area President of Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 to November 2010 and Area President of Europe, Africa and Middle East of Pfizer Animal Health from 2005 to 2009 Mr. Albert Bourla, DVM, Ph.D., has been Group President of Pfizer Innovative Health at Pfizer Inc. since June 2016. Mr. Bourla served as Group President of Global Innovative Pharma & Global Vaccines, Oncology & Consumer Healthcare Businesses at Pfizer Inc. since February 12, 2016 until July 1, 2016. Mr. Bourla served as Group President of the Vaccines, Oncology and Consumer Healthcare Business at Pfizer Inc. since January 1, 2014. Mr. Bourla served as President and General Manager of Established Products Business Unit at Pfizer Inc., from December 2010 to December 2013 and served as its Area President of Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 to November 2010 and Area President of Europe, Africa and Middle East of Pfizer Animal Health from 2005 to 2009
Research Interest
Business
